ArticlePDF Available

Incorporating environmental impacts into the economic evaluation of health care systems: Perspectives from ecological economics

Authors:

Abstract

Health care is responsible for a range of negative environmental impacts, including greenhouse gas emissions, air pollution, plastics waste, and pharmaceutical pollution of ecosystems through excretion and inappropriate disposal. Evidence on the scale of these impacts has been growing in high-income countries. To date, there has been only limited discussion of how environmental impacts might be incorporated into economic evaluations of health care programs, including health technology assessment. This paper considers why and how this aim might be achieved, using perspectives from both mainstream and ecological economics. There are strong arguments for using economic evaluation to internalise the negative environmental externalities currently being generated by health care, as well as precautionary arguments for health systems to better understand their exposure to their environmental impacts. The paper tests the feasibility of incorporating the costs of greenhouse gas emissions within costing for economic evaluation, and concludes that the use of shadow prices to achieve this aim is feasible. It suggests that this cost-based approach is preferable to more convoluted attempts to incorporate environmental impacts in the outcome component of health economic evaluations. The interaction between overuse, antimicrobial resistance and environmental harms of health care is identified as an area that would benefit from investigation using innovative economic methods. Until 28 th January 2020, you can read the full text of this article online for free via the Elsevier Share Link at: https://authors.elsevier.com/a/1aCIh3HVLKeNnE
Hensher M. (2020)
Incorporating environmental impacts into the economic evaluation of health care systems:
Perspectives from ecological economics. Resources, Conservation and Recycling 154:
104623.
https://doi.org/10.1016/j.resconrec.2019.104623
Abstract
Health care is responsible for a range of negative environmental impacts, including
greenhouse gas emissions, air pollution, plastics waste, and pharmaceutical pollution of
ecosystems through excretion and inappropriate disposal. Evidence on the scale of these
impacts has been growing in high-income countries. To date, there has been only limited
discussion of how environmental impacts might be incorporated into economic evaluations
of health care programs, including health technology assessment. This paper considers why
and how this aim might be achieved, using perspectives from both mainstream and ecological
economics. There are strong arguments for using economic evaluation to internalise the
negative environmental externalities currently being generated by health care, as well as
precautionary arguments for health systems to better understand their exposure to their
environmental impacts. The paper tests the feasibility of incorporating the costs of
greenhouse gas emissions within costing for economic evaluation, and concludes that the use
of shadow prices to achieve this aim is feasible. It suggests that this cost-based approach is
preferable to more convoluted attempts to incorporate environmental impacts in the
outcome component of health economic evaluations. The interaction between overuse,
antimicrobial resistance and environmental harms of health care is identified as an area that
would benefit from investigation using innovative economic methods.
Until 28th January 2020, you can read the full text of this article online for
free via the Elsevier Share Link at:
https://authors.elsevier.com/a/1aCIh3HVLKeNnE
... Indeed, the question of how environmental impacts should be best incorporated into the healthcare commissioning Professional matters process (to some extent similar to other scientific findings) is a point of active debate. 25 Greener NHS has already declared that procurement decisions will be influenced by suppliers' alignment with the NHS net-zero ambition: their roadmap states that by 2030 'suppliers will only be able to qualify for NHS contracts if they can demonstrate their progress through published progress reports and continued carbon emissions reporting'. 26 The role of environmental impact data in influencing the design of care models and services is perhaps even more complex, and the UK's National Institute of Clinical Excellence is examining how environmental sustainability considerations should be included in a new framework for prioritising topics across their recommendations. ...
Article
Concern regarding the environmental impact of healthcare provision is now accompanied by a legal commitment for the NHS to align itself with national emissions targets. Meanwhile, the academic literature increasingly features environmental impact assessments focused on healthcare products, processes and systems. However, the current evidence base contains significant methodological heterogeneity, and the healthcare context demands that particular considerations are made when interpreting the findings from these studies. In this article, we consider the role environmental accounting methodologies can play in the effort to achieve environmental sustainability in healthcare; their utility and limitations.
... By contrast, the much larger group of products whose environmental consequences are primarily generic in nature would be more cost-effectively dealt with via appropriate generic analysis and policy instruments targeting these general mechanisms of impact. Such an approach requires two critical elements to be in place: (1) an effective environmental screening assessment to identify early on any intrinsic impact characteristics of products (10), and (2) genuine integration of HTA environmental assessment processes within a wider armamentarium of effective policy measures to control generic environmental impacts. Figure 2 also illustrates the increasing importance of resilience for HTA, especially as climate change impacts themselves increasingly become felt in supply chains (see Box 1). ...
Article
Full-text available
The growing global focus on and sense of urgency toward improving healthcare environmental sustainability and moving to low-carbon and resilient healthcare systems is increasingly mirrored in discussions of the role of health technology assessment (HTA). This Perspective considers how HTA can most effectively contribute to these goals and where other policy tools may be more effective in driving sustainability, especially given the highly limited pool of resources available to conduct environmental assessments within HTA. It suggests that HTA might most productively focus on assessing those technologies that have intrinsic characteristics which may cause specific environmental harms or vulnerabilities, while the generic environmental impacts of most other products may be better addressed through other policy and regulatory mechanisms.
Article
Introduction Every industry has greenhouse gas emissions, with healthcare a significant contributor. In Canada, the healthcare sector is directly and indirectly responsible for 4.6% of the country's greenhouse gas emissions. Operating rooms (ORs) are major contributors to hospital waste, making the OR low hanging fruit for analyzing environmental practices. The OR can adopt a green mindset to reduce its carbon footprint, yet barriers to going green exist. Herein we study non-hospital surgical centres in British Columbia to assess current green practices, attitudes towards environmental sustainability, and barriers to implementation. Methods All accredited non-hospital surgical centres in BC were invited to complete a survey on current practices and plans to reduce their environmental impact. Results Of 56 non-hospital surgical centres contacted, 18 responded, with 89% willing to adapt their practice to promote environmental sustainability, yet lacked current knowledge (56%) and formal plans (0%). The wide use of anesthetic gases with high global warming potential (64%) and disposable drapes/ gowns (78%/ 67%) were noted. Barriers to adopting green practices included: cost (44%), infrastructure (44%), regulatory guidelines (39%), knowledge (39%), and safety (28%). Conclusions Transitioning to more environmentally sustainable practices in ORs can enhance healthcare value by reducing both costs and greenhouse gas emissions. The greatest effect can be achieved through prudent choice of anesthetic gas agent, followed by reusable linens and drapes. Education and regulatory leadership were identified as crucial for overcoming these barriers. This study underscores the need for education, guidelines, and economically viable options to transition from awareness to action.
Article
Economic evaluation aims to compare the costs and results of health strategies to inform public decision making. Although sometimes suggested, until now no national evaluation agency has recommended formally incorporating the cost of greenhouse gas (GHG) emissions generated by health interventions into the estimation of healthcare costs. The objective of this study was to test and discuss the feasibility of estimating and including the contribution of GHG emissions cost to the total cost of a surgical intervention, with the example of robot-assisted total knee arthroplasty (RTA), using a micro-costing approach. The study was conducted in June 2022 at the William Morey Hospital (France). Data regarding all of the resources (labor, medical equipment, consumables), as well as energy consumption, staff commuting and waste treatment were collected and valued from the hospital point of view. Greenhouse gas emissions were valued using a cost-effectiveness approach. Several sensitivity analyses were performed. The mean cost per patient of an RTA was estimated to be €4755.65, of which €152.64 (3.21 %) would be attributable to GHG emissions. The contribution of GHG emissions in the overall cost of a health intervention was highly dependent on the convention used for the price of carbon. Despite persistent theoretical and practical challenges, adding the estimation of GHG emission costs in the economic evaluation of health interventions may provide institutional decision makers with information that allows them to allocate the public healthcare resources more efficiently.
Article
Full-text available
Healthcare systems are major emitters of greenhouse gases that contribute to climate change. The resulting climate crisis harms human and planetary health and increasingly impacts lives on Earth. Because of their status as high emitters and their social role in society, healthcare systems have a clear obligation to decarbonise. This study investigates how healthcare systems worldwide can lower their greenhouse gas emissions and thereby contribute to global climate action. We performed a systematic literature review, searching PubMed, GreenFILE, Business Source Complete and CINAHL for relevant empirical studies, non-research papers and grey literature published between 1 January 2018 and 28 March 2023. The Greenhouse Gas Protocol applied to healthcare systems guided thematic and descriptive analyses to explore interventions targeted at scope 1, 2 and 3 emissions. The PRISMA guidelines were followed for reporting and synthesising the results. A total of 742 publications were initially identified, 230 of which were included in the systematic literature review, comprising 96 empirical studies, 132 non-research papers and two governmental reports. Numerous conventional and unique decarbonisation actions related to healthcare have been reported in the literature. Eight themes were identified: transportation, anaesthesia, energy, travel, supply chain, clinical practices, planetary health literacy and system changes. This study shows the abundant potential for healthcare decarbonisation while highlighting key uncertainties around decarbonisation in healthcare and providing ambitious recommendations to lower emissions globally. Decarbonisation actions are needed at the personal, organisational and system levels. The health workforce is vital in driving transformative change but needs to be adequately trained and educated about the importance of low-carbon solutions in healthcare. Countries worldwide must exchange knowledge about successful decarbonisation interventions and best practices to push global progress. Looking forward, action plans and audits at the local level combined with large-scale measures and policies are needed to influence the system as a whole.
Article
Introduction: Health economic evaluation (HEE) provides guidance for decision-making in the face of scarcity but ignores ecological scarcities as long as they involve external costs only. Following the imperative to account for planetary health, this study explores how this blind spot can be addressed. Areas covered: The study is based on a critical review of relevant work, particularly in the fields of HEE and life cycle assessment (LCA). LCA can provide information on a technology's environmental impacts which can be accounted for on both the effect and cost sides of HEE. Cost-benefit analyses can incorporate environmental impacts in case vignettes used for eliciting consumers' willingness to pay. Existing LCA impact models can be used to estimate human health risks associated with environmental impacts and add them to the health benefits in cost-utility analyses. Many jurisdictions offer lists of shadow prices that can be used to incorporate environmental impacts on the cost side of HEE. Also, environmental impacts can be reported in a disaggregated manner. Expert opinion: Accounting for planetary boundaries is likely to become a key field of methodological innovation in HEE. Decision relevance is likely to be highest for technologies with similar cost-effectiveness but different ecological impacts.
Article
Economic evaluations aim to compare the costs and the results of health strategies to guide the public decision-making process. Cost estimation is, thus, a cornerstone of this approach. At present, few national evaluation agencies recommend incorporating the cost of greenhouse gas (GHG) emissions from healthcare actions into the calculation of healthcare costs. Our main goal is to describe and discuss the methodology for integrating the cost of GHG emissions into the field of applied economic evaluations. To estimate this cost, three steps are required: (1) identifying and quantifying the physical flows linked to the production and management of the outputs of healthcare interventions, (2) estimating the quantity of GHG that can be attributed to each physical flow, and (3) valuing these GHG emissions in monetary terms. Integrating the cost of GHG emissions into the calculation of the costs of healthcare interventions is both useful and relevant from a perspective of collective intergenerational well-being. This approach has been made possible thanks to the existence of accounting and monetary valuation methods for emissions. Agencies specialized in health economic evaluations could take up this issue to resolve ongoing questions, thus providing researchers with a methodological framework and public decision-makers with some key insights.
Research
Full-text available
This paper is all about the healthcare system that exist already and a brief comparison between them. The health effects related to air pollution are monitored and reported in a healthcare system. These systems are designed in order to monitor the indoor as well as the outdoor air pollution. WHO (World Health Organization) claims that the hazards that come through air pollution are increasing day by day and the main cause for these are vehicles, factories and emission of harmful gases into the atmosphere. Various reports suggest that air pollution exposure for longer time can lead to many respiratory problems. Data that is collected by the organization about air pollution has to be utilized very effectively. In this paper, we have analyzed the impact of air pollution on humans.
Article
Full-text available
The strong and positive relationship between gross domestic product (GDP) and health expenditure is one of the most extensively explored topics in health economics. Since the global financial crisis, a variety of theories attempting to explain the slow recovery of the global economy have predicted that future economic growth will be slower than in the past. Others have increasingly questioned whether GDP growth is desirable or sustainable in the long term as evidence grows of humanity's impact on the natural environment. This paper reviews recent data on trends in global GDP growth and health expenditure. It examines a range of theories and scenarios concerning future global GDP growth prospects. It then considers the potential implications for health care systems and health financing policy of these different scenarios. In all cases, a core question concerns whether growth in GDP and/or growth in health expenditure in fact increases human health and well-being. Health care systems in low growth or ‘post-growth’ futures will need to be much more tightly focused on reducing overtreatment and low value care, reducing environmental impact, and on improving technical and allocative efficiency. This will require much more concerted policy and regulatory action to reduce industry rent-seeking behaviours.
Article
Full-text available
The healthcare sector is one of the largest polluters in the UK, accounting for 25% of total emissions of carbon dioxide of the public sector. Ironically, it is the healthcare sector itself that is primarily affected by any deterioration in the environment affecting individuals' health and their demand for healthcare. Therefore, the healthcare sector is a direct beneficiary of its own steps towards sustainability and is more and more viewed as the one who should lead the change. In this article, we first review the concepts of financial and environmental sustainability. Second, we discuss the existing evidence of sustainable changes within this sector. Third, we propose a simple adaptation of the classic cost-effectiveness analysis to incorporate carbon footprinting to account for these external costs. We illustrate our method using the case of in-centre versus home haemodialysis. We conclude that home dialysis is always a preferable alternative to in-centre treatment based on a cost-effectiveness analysis. Finally, we discuss the limitations of our approach and the future research agenda.
Article
Full-text available
Circular economy is presented as a sustainable alternative to the take-make-waste society. The discourse on circular economy emphasizes the role of durable products, while consumable products are less in focus, although resources efficiency is needed for all types of products. This paper aims to contribute knowledge on resource efficient measures that are possible to implement for consumables and to evaluate their resource efficiency potential by means of a case study on incontinence products using life cycle assessment. Four possible measures were identified that can be implemented at different stages of the value-chain, to increase their resource efficiency. The study was delimited to measures possible to implement using current technology. The measures were: recycling of waste generated in production, increasing the share of bio-based material in the product, shifting to a partly reusable product system and more effective use of products through customization to user’s needs. Effective use of products through customization led to at least 20% decrease in environmental impact with no trade-offs between studied impact categories. However, when looking at global warming potential only, the partly reusable product system was found to decrease environmental impact with more than 50% compared to a corresponding disposable product. Moreover, many resource efficient measures were identified as being possible to implement for consumables, and in the case of incontinence products a combination of measures was possible.
Article
Full-text available
Background: Comprehensive and comparable estimates of health spending in each country are a key input for health policy and planning, and are necessary to support the achievement of national and international health goals. Previous studies have tracked past and projected future health spending until 2040 and shown that, with economic development, countries tend to spend more on health per capita, with a decreasing share of spending from development assistance and out-of-pocket sources. We aimed to characterise the past, present, and predicted future of global health spending, with an emphasis on equity in spending across countries. Methods: We estimated domestic health spending for 195 countries and territories from 1995 to 2016, split into three categories-government, out-of-pocket, and prepaid private health spending-and estimated development assistance for health (DAH) from 1990 to 2018. We estimated future scenarios of health spending using an ensemble of linear mixed-effects models with time series specifications to project domestic health spending from 2017 through 2050 and DAH from 2019 through 2050. Data were extracted from a broad set of sources tracking health spending and revenue, and were standardised and converted to inflation-adjusted 2018 US dollars. Incomplete or low-quality data were modelled and uncertainty was estimated, leading to a complete data series of total, government, prepaid private, and out-of-pocket health spending, and DAH. Estimates are reported in 2018 US dollars, 2018 purchasing-power parity-adjusted dollars, and as a percentage of gross domestic product. We used demographic decomposition methods to assess a set of factors associated with changes in government health spending between 1995 and 2016 and to examine evidence to support the theory of the health financing transition. We projected two alternative future scenarios based on higher government health spending to assess the potential ability of governments to generate more resources for health. Findings: Between 1995 and 2016, health spending grew at a rate of 4·00% (95% uncertainty interval 3·89-4·12) annually, although it grew slower in per capita terms (2·72% [2·61-2·84]) and increased by less than 1percapitaoverthisperiodin22of195countries.Thehighestannualgrowthratesinpercapitahealthspendingwereobservedinuppermiddleincomecountries(5551 per capita over this period in 22 of 195 countries. The highest annual growth rates in per capita health spending were observed in upper-middle-income countries (5·55% [5·18-5·95]), mainly due to growth in government health spending, and in lower-middle-income countries (3·71% [3·10-4·34]), mainly from DAH. Health spending globally reached 8·0 trillion (7·8-8·1) in 2016 (comprising 8·6% [8·4-8·7] of the global economy and 103trillion[101106]inpurchasingpowerparityadjusteddollars),withapercapitaspendingofUS10·3 trillion [10·1-10·6] in purchasing-power parity-adjusted dollars), with a per capita spending of US5252 (5184-5319) in high-income countries, 491(461524)inuppermiddleincomecountries,491 (461-524) in upper-middle-income countries, 81 (74-89) in lower-middle-income countries, and 40(3843)inlowincomecountries.In2016,0440 (38-43) in low-income countries. In 2016, 0·4% (0·3-0·4) of health spending globally was in low-income countries, despite these countries comprising 10·0% of the global population. In 2018, the largest proportion of DAH targeted HIV/AIDS (9·5 billion, 24·3% of total DAH), although spending on other infectious diseases (excluding tuberculosis and malaria) grew fastest from 2010 to 2018 (6·27% per year). The leading sources of DAH were the USA and private philanthropy (excluding corporate donations and the Bill & Melinda Gates Foundation). For the first time, we included estimates of China's contribution to DAH (6447millionin2018).Globally,healthspendingisprojectedtoincreaseto644·7 million in 2018). Globally, health spending is projected to increase to 15·0 trillion (14·0-16·0) by 2050 (reaching 9·4% [7·6-11·3] of the global economy and $21·3 trillion [19·8-23·1] in purchasing-power parity-adjusted dollars), but at a lower growth rate of 1·84% (1·68-2·02) annually, and with continuing disparities in spending between countries. In 2050, we estimate that 0·6% (0·6-0·7) of health spending will occur in currently low-income countries, despite these countries comprising an estimated 15·7% of the global population by 2050. The ratio between per capita health spending in high-income and low-income countries was 130·2 (122·9-136·9) in 2016 and is projected to remain at similar levels in 2050 (125·9 [113·7-138·1]). The decomposition analysis identified governments' increased prioritisation of the health sector and economic development as the strongest factors associated with increases in government health spending globally. Future government health spending scenarios suggest that, with greater prioritisation of the health sector and increased government spending, health spending per capita could more than double, with greater impacts in countries that currently have the lowest levels of government health spending. Interpretation: Financing for global health has increased steadily over the past two decades and is projected to continue increasing in the future, although at a slower pace of growth and with persistent disparities in per-capita health spending between countries. Out-of-pocket spending is projected to remain substantial outside of high-income countries. Many low-income countries are expected to remain dependent on development assistance, although with greater government spending, larger investments in health are feasible. In the absence of sustained new investments in health, increasing efficiency in health spending is essential to meet global health targets. Funding: Bill & Melinda Gates Foundation.
Article
While vastly differing in scale, each nation's health sector directly and indirectly releases greenhouse gases (GHG) through energy consumption, transport, and product manufacture, use, and disposal. Until recently, however, the health sector has not been measured as a coherent segment of the world's climate footprint. A 2019 report by Health Care Without Harm, in collaboration with Arup, provides the most comprehensive global analysis of health care's contribution to climate change to date, based on full global coverage of spending data together with detailed information from 43 countries. It identifies key sources of health care emissions while allowing for comparison between nations and among many regions of the world. Among the report's key findings are that health care's climate footprint is equivalent to 4.4% of global net emissions; that the top three health care emitters-the United States, China, and the European Union-comprise more than half of the global footprint; and that 71% of emissions are derived from the health care supply chain. The findings inform a series of international, national, and subnational policy recommendations for health care climate action, and it identifies opportunities for further research and methodological development to support the health sector in its efforts to understand and address its climate footprint. Additional findings from 2020 will also be presented. Ultimately, these estimates of health care's climate footprint provide the baseline information needed to devise pathways and track progress toward health care de-carbonization across the sector.
Article
Importance Reducing the carbon footprint of the healthcare sector can be achieved along with quality patient outcomes at lower environmental impact. Objective For the first time to categorize peer-reviewed articles that report quantitative improvement in greenhouse gas emissions related to medical devices and services, overview of trends, and identify some gaps for future research. Data sources Database searches resulted in 822 peer-reviewed articles (January 1, 2000 and December 31, 2016) on healthcare and environmental sustainability. Study selection A systematic review methodology identifies, critically evaluates, and integrates the findings. Articles reviewed 1) provided quantitative global warming potential (GWP) information, 2) were published in peer-reviewed journals, and 3) were related to one of the twelve hospital service categories. Results Patient care teams are substantially limited by a lack of data related to the environmental impact of their services. Of the one of three potential environmental scopes—travel-related energy, direct energy, and the procured goods and equipment embodied energy—only six articles covered all three scopes. Conclusions and relevance This research provides healthcare nurses, physicians, and administrators with the location of procedures, patient-based decisions, and other avenues to hospital sustainability improvements in twelve hospital service categories.
Article
The carbon footprint of Japanese health care services, i.e. the domestic greenhouse gas (GHG) emissions caused by health care expenditures, including the associated fixed capital, were calculated using input-output analysis. In 2011 the total carbon footprint of these services was 62.5 × 10^6 metric tons of CO 2 equivalent (MtCO2e), which is 4.6% of total domestic GHG emissions. Medical services involving hospitalization accounted for the greatest share, at 15.7 MtCO2e. The second highest category, Medical services without hospitalization, accounted for only slightly less: 14.2 MtCO2e. However, the difference in emissions per patient between these two categories was considerable. On average, emissions per patient for Medical services (hospitalization) were 12 tCO2 e/patient, whereas for Medical services (non-hospitalization) they were only 2.1 tCO2 e/patient, or 5.4 times less. In terms of type of medical condition, the greatest annual emissions were associated with cardiovascular disease (6.2 MtCO2e) and neoplasm (4.0 MtCO2e). In terms of age, emissions attributed to patients aged 65 and over accounted for more than half of total health care emissions. By 2015, the total carbon footprint had increased to 72.0 MtCO2e, a rise of over 15% in four years. Although medical care and pharmaceuticals are the main factors responsible for this increase, emissions associated with nursing services have also risen, suggesting that demographic aging may be having a significant impact on GHG emissions. As a countermeasure, the potential annual GHG mitigation achievable through avoidance of unused prescribed medicines resulting in waste was estimated at 1.24 MtCO2e, comparable with the total carbon footprint of home medicines. To safeguard planetary health, in addition to implementing technological improvements to the supply chains of health care services, it will be necessary to provide citizens further options for achieving health promotion and GHG mitigation simultaneously.